Biotechnology in Europe: Investing in the future

The 2020 edition of the European Biotech Week took place from 28^th of September until 4^th of October. It celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech Week that took place in 2013 marked the 60th anniversary of this pivotal moment in history.

On the 29^th September, EuropaBio, the European Association for bioindustries, Europe´s largest and most influential biotech industry group and Invest Europe, European Private Equity & Venture Capital Association that represent the private equity community across Europe, organised a round table to discuss about the Future of European investments in the biotech sector.

Mr. Rainer Strohmenger from Wellington Partners and Ms Sandra Ferri, from the European Investment Fund, representing the private and public investors ecosystem, discussed about investments with Mr. Cedric Ververken, CEO of Confo Therapeutics and Ms. Marisa Hernández Latorre CEO of Ingelia, representing the European biotech companies.

Marisa Hernández Latorre focused on industrial investments and the importance of aligning objectives with investors to develop business in Europe.

More information on the following link:

https://www.europabio.org/events/biotechnology-europe-investing-future